Delivery Order SPE2DB24D3013-SPE2DB25FFNSD
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,406.58 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pen (0.5ml), a diabetes medication. The contract was awarded on a firm fixed-price basis without a set-aside designation, with an ultimate completion date of June 3, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $4,632.52 firm fixed-price delivery order on September 10, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pens, a widely-used injectable medication for type 2 diabetes management. The contract is unset-aside and competitively awarded, with performance to be completed by September 11, 2025, at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under...
- The Defense Logistics Agency awarded a delivery order valued at $6,231.30 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 mL pens (0.5 mL units), a diabetes medication. This firm fixed price, competitively awarded contract has an ultimate completion date of August 26, 2025, with performance conducted at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,580.59 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL units), a diabetes medication used within military and federal healthcare systems. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of August 15, 2025, and represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. AmerisourceBergen, headquartered...
- The Defense Logistics Agency awarded a delivery order valued at $2,338.05 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pen (0.5 ml), a diabetes management medication. This firm fixed-price, non-set-aside contract was awarded on June 9, 2025, with an ultimate completion date of June 10, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $7,615.33 on September 16, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL). This competitively awarded, firm fixed-price contract carries an ultimate completion date of September 17, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $3,022.98 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 ml pens on June 6, 2025, with completion targeted for June 9, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award was made on a competitive, non-set-aside basis to fulfill...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,277.38 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens on September 10, 2025, with completion targeted for September 11, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitively awarded procurement fulfilled by AmerisourceBergen's Corporate Office located in Conshohocken, Pennsylvania. The contract is issued as a child order under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,746.30 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens (0.5 mL units), a diabetes management medication. The award, issued on July 18, 2025, with an ultimate completion date of July 21, 2025, reflects a firm fixed-price contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, executed the delivery order from its corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pens valued at $3,713.25 with a firm fixed price structure. This competitive award, issued on June 2, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a potential value of $999,999,999.00 through December 2026. The pharmaceutical product will be performed from the vendor's...
- SPE2DB24D3013Indefinite Delivery Contract
- SPE2DB24D3013-SPE2DB25FFNSDDelivery Order
The Defense Logistics Agency has awarded AmerisourceBergen Drug Corp a delivery order valued at $3,517.58 for Trulicity 0.75 mg/0.5 ml pen (0.5ml), a diabetes medication. The contract is classified as firm fixed price with no set-aside designation and is scheduled for completion by July 28, 2025. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.99 million through December 2026, which serves as the primary pharmaceutical supply vehicle for military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal healthcare vendor that maintains extensive contracts with the Defense Logistics Agency to supply pharmaceuticals, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The company's federal procurement portfolio demonstrates consistent capability to deliver brand-name and generic medications, including specialty drugs for diabetes management, neurological conditions, and pain management, to support military and veteran healthcare systems. This competitive award reflects AmerisourceBergen's established position as a primary pharmaceutical supplier to federal customers, including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 7/25/25 |